Virtus Biotech ETF
BBP
17 hedge funds and large institutions have $11.9M invested in Virtus Biotech ETF in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
13% more funds holding
Funds holding: 15 → 17 (+2)
11% more capital inflows, than outflows
Capital inflows: $1.42M | Capital outflows: $1.28M
3.49% more ownership
Funds ownership: 38.51% → 42% (+3.5%)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.11M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$200K |
| 3 |
Smart Money Group
Eastland,
Texas
|
+$46K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$3.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.07M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$70.8K |
| 3 |
Financial Advocates Investment Management
Olympia,
Washington
|
-$48.2K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$33.2K |
| 5 |
Plante Moran Financial Advisors
Southfield,
Michigan
|
-$30K |
BBP Hedge Fund Activity: Q4 2019 in Review
17 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2019, worth a combined $11.9M — up 23% from $9.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BBP positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 8 trimmed.
The largest buyer was Jane Street, adding an estimated $1.11M. The largest seller was Royal Bank of Canada, cutting an estimated $1.07M.
- 17 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2019, up from 15 in Q3 2019.
- Funds reported $11.9M of Virtus Biotech ETF stock for Q4 2019, up 23% quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q4 2019 and 1 closed out, a net change of +2 holders.
- The largest Virtus Biotech ETF buyer in Q4 2019 was Jane Street, an estimated $1.11M added.
- The largest Virtus Biotech ETF seller in Q4 2019 was Royal Bank of Canada, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2019.